GlassScriptPhysician profile
Cristopher J Matthews
NPI 1841718780
$1,014.33
in general payments reported to CMS, 2019-2025
18 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.27 · 2022: $235 · 2023: $323 · 2024: $264 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $191.14 | 2022-2024 | Yupelri |
| Novo Nordisk INC | $167.97 | 2022-2024 | Ozempic, Saxenda, Wegovy |
| Abbvie INC. | $129.81 | 2022-2024 | |
| Exact Sciences Corporation | $92.27 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $86.24 | 2021-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $65.76 | 2022 | |
| Viatris Specialty LLC | $57.23 | 2025 | Yupelri |
| Dexcom, INC. | $42.86 | 2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $28.25 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $22.60 | 2023 | Breztri |
| Trevena, INC. | $21.53 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.44 | 2021 | |
| Abbott Laboratories | $18.43 | 2025 | Cardiomems |
| Pfizer INC. | $15.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.91 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.10 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.09 | 2021 | |
| Amgen INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristopher Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.